share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 7 04:54
Summary by Futu AI
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated